Nogra Pharma is available to give comprehensive Project presentations, provide additional Project specific details or confidential information and discuss potential collaborations or out-licensing opportunities with interested companies.
![Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment](https://www.nographarma.com/wp-content/uploads/2023/01/NograPharma_Torii_Pharmaceutical.jpg)
Nogra Pharma announces out-licensing agreement with Torii Pharmaceutical for Japan for New Chemical Entity topical acne treatment
Dublin, Ireland, 26 January 2023, Nogra Pharma today announces officially it has entered into an out-licensing agreement with Torii Pharmaceutical Co., Ltd. (Torii) (TSE:4551), to further develop and commercialise NAC-GED-0507 in Japan for the treatment of acne vulgaris.
Read More